Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Drug Manufacturers - Major Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > i wonder what has happened to the FDA APPLICATION
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(328)
•••
Comment by Golddetectoron Feb 15, 2022 1:52pm
156 Views
Post# 34430808

RE:RE:RE:RE:RE:i wonder what has happened to the FDA APPLICATION

RE:RE:RE:RE:RE:i wonder what has happened to the FDA APPLICATIONImo management is responsible to protect shareholders interest. Part of the job is cut the road on these shorts. Is there any reason that this lost 75% of its value since may? Technically no we are way closer to results. So we should be ip. But when you do not provide updates this happens. Yes small cap market condition and mj pullback but not to 10c this did happen during Covid-19 time and we did not even have trials going on. Guy has to understand that. Anyway we are where we are it is all time low. For me it doesn't matter if it is 10c or 14c. It is way undervalued. As for QIXLEEF and Reduvo I strongly believe it work. Look at the graphs from last presentation this presentation is done after trial almost complete so it works just a matter of time 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities